7Iwanaga Y. Physicochemical and pharmacological characteristic and clinical efficacy of an antiirritable bowel syndrome agent,polycarbophil calcium[J] .Nippon Yakurigaku Zasshi, 2002, 119 (3):185-190.
8Khoshoo V, Armstead C, Landry L. Effect of a laxative with and without tegaserod in adolescents with constipation predo minant irritable bowel syndrome[J] .Aliment Pharmacol Ther, 2006,23 (1):191-196.
9Chey WD, Saad R, Panas R, et al.Discontinuation of lubiprostone treatment for irritable bowel syndrome wilh constipation is not associated with symptom increase or recurrence:results from a randomized withdrawal study[J] .Gastroenterology, 2008, 134 (4):A401.
